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Abstract
Background: Preterm delivery causes substantial neonatal mortality and morbidity. Unrecognized intra-amniotic infections
caused by cultivation-resistant microbes may play a role. Molecular methods can detect, characterize and quantify microbes
independently of traditional culture techniques. However, molecular studies that define the diversity and abundance of
microbes invading the amniotic cavity, and evaluate their clinical significance within a causal framework, are lacking.
Methods and Findings: In parallel with culture, we used broad-range end-point and real-time PCR assays to amplify,
identify and quantify ribosomal DNA (rDNA) of bacteria, fungi and archaea from amniotic fluid of 166 women in preterm
labor with intact membranes. We sequenced up to 24 rRNA clones per positive specimen and assigned taxonomic
designations to approximately the species level. Microbial prevalence, diversity and abundance were correlated with host
inflammation and with gestational and neonatal outcomes. Study subjects who delivered at term served as controls. The
combined use of molecular and culture methods revealed a greater prevalence (15% of subjects) and diversity (18 taxa) of
microbes in amniotic fluid than did culture alone (9.6% of subjects; 11 taxa). The taxa detected only by PCR included a
related group of fastidious bacteria, comprised of Sneathia sanguinegens, Leptotrichia amnionii and an unassigned,
uncultivated, and previously-uncharacterized bacterium; one or more members of this group were detected in 25% of
positive specimens. A positive PCR was associated with histologic chorioamnionitis (adjusted odds ratio [OR] 20; 95% CI, 2.4
to 172), and funisitis (adjusted OR 18; 95% CI, 3.1 to 99). The positive predictive value of PCR for preterm delivery was 100
percent. A temporal association between a positive PCR and delivery was supported by a shortened amniocentesis-to-
delivery interval (adjusted hazard ratio 4.6; 95% CI, 2.2 to 9.5). A dose-response association was demonstrated between
bacterial rDNA abundance and gestational age at delivery (r
2=0.42; P,0.002).
Conclusions: The amniotic cavity of women in preterm labor harbors DNA from a greater diversity of microbes than
previously suspected, including as-yet uncultivated, previously-uncharacterized taxa. The strength, temporality and gradient
with which these microbial sequence types are associated with preterm delivery support a causal relationship.
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Introduction
Preterm birth is the leading cause of neonatal mortality
worldwide [1], yet its underlying etiologies remain largely
unknown [2,3]. Mortality exhibits an inverse relationship with
gestational age, such that early preterm neonates (e.g., less than 32
gestational weeks) account for the vast majority of deaths [4–6].
Consequently, the need for insights into factors contributing to
early preterm delivery is particularly acute.
A strong body of evidence suggests that occult intra-uterine
infection plays a major role in preterm labor and delivery [7].
These infections are thought to escape detection primarily
because they are subclinical, but also because they may be
caused by cultivation-resistant microbes [8]. Fastidious bacterial
taxa, such as mycoplasmas, are among those most commonly
implicated in preterm birth [8–11], but the specialized techniques
required to cultivate them reliably are seldom used in clinical
settings [9–11]. Other microbial groups, including the majority of
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methods [12].
Molecular methods such as polymerase chain reaction (PCR)
can detect microbes independently of culture. Moreover, broad-
range PCR assays that amplify highly-conserved but phylogenet-
ically-informative gene sequences can identify microbes across
broad taxonomic levels, including previously uncharacterized
species. By overcoming investigator biases inherent to more
specific detection methods, sequencing of broad-range PCR
products has emerged as a powerful approach for revealing
previously unsuspected microbial diversity in various anatomic
niches in human health [13] and disease [14], and for
characterizing uncultivated human pathogens [15].
The application of broad-range PCR to amniotic fluid has been
limited to date. In particular, molecular investigations that
characterize the microbial diversity of the amniotic cavity in a
systematic manner, and evaluate findings within a coherent causal
framework, are lacking. As an early step in defining the potential
role of diverse microbial sequence types, including uncultivated
taxa, in preterm delivery, we conducted a broad-range molecular
investigation. In parallel with traditional amniotic fluid cultures,
we used qualitative and quantitative PCR assays to amplify,
identify and quantify ribosomal DNA (rDNA) of bacteria, fungi
and archaea from amniotic fluid of patients with spontaneous
preterm labor and intact membranes. We examined sequence
diversity in samples with detectable rDNA, and correlated findings
with pre-specified measures of host inflammation, as well as
pregnancy and neonatal outcome. We sought evidence for the
types of associations that have been proposed as alternatives to
Koch’s postulates for inferring causality from molecular data (e.g.,
associations of space, time and dose) [16]. Here, we report the
prevalence, diversity and abundance of microbes in amniotic fluid
during preterm labor, and their clinical significance.
Methods
Study population
A retrospective cohort study was conducted by searching our
clinical databaseto identify patients with the diagnosis of spontaneous
preterm labor with intact membranes, enrolled at Hutzel Women’s
Hospital (Detroit, MI) between October 1998 and December 2002,
who provided written informed consent and for whom an adequate
volume of amniotic fluid was available with which to conduct these
research assays after clinically-indicated conventional analyses were
completed.Patientswereincludediftheymetthefollowingcriteria:1)
singleton gestation; 2) gestational age between 18 and 35 weeks; and
3) had an amniocentesis with microbiological studies of amniotic
fluid. Patients were excluded from the study if: 1) rupture of the
chorioamnioticmembranes occurred before amniotic fluid collection;
2) the amniotic fluid was collected transvaginally; 3) delivery occurred
elsewhere and/or clinical data were unavailable; and 4) a major fetal
congenital anomaly was present.
A total of 166 subjects were included in this study. The pre-
specified control group consisted of study subjects who delivered at
term. All women provided written informed consent prior to the
collection of biological samples. The utilization of samples for
research purposes was approved by the Institutional Review
Boards of Wayne State University, the National Institute of Child
Health and Human Development (NICHD/NIH/DHHS), and
Stanford University.
Definitions
Preterm labor was diagnosed by the presence of at least two
regular uterine contractions every 10 minutes associated with
cervical changes that required hospital admission before 37 weeks
of gestation. Preterm delivery was defined as delivery before 37
weeks of gestation. Clinical chorioamnionitis was diagnosed
according to criteria previously proposed [17], including maternal
temperature of $37.8uC and two or more of the following criteria:
uterine tenderness, malodorous vaginal discharge, maternal
leukocytosis ($15000 cells/mm
3), maternal tachycardia (.100
beats/min) and fetal tachycardia (.160 beats/min). Histologic
chorioamnionitis was diagnosed based on the presence of
inflammatory cells in the chorionic plate and/or chorioamniotic
membranes. Acute funisitis was diagnosed by the presence of
neutrophils in the wall of the umbilical vessels and/or Wharton’s
jelly using criteria previously described [18].
Sampling procedures
Enrolled subjects underwent transabdominal, ultrasound-guid-
ed amniocentesis, which is within the standard of care at Hutzel
Women’s Hospital for evaluating possible microbial invasion of the
amniotic cavity of patients with spontaneous preterm labor.
Amniotic fluid was immediately transported in a capped sterile
syringe to the clinical laboratory where it was cultured for aerobic
and anaerobic bacteria, including genital mycoplasmas. White
blood cell (WBC) count and Gram stain of amniotic fluid were also
performed shortly after collection. Amniotic fluid not required for
clinical assessment was centrifuged for 10 minutes at 4uC shortly
after the amniocentesis, and the supernatant was aliquoted and
stored at 270uC until analysis. Amniotic fluid IL-6 concentrations
were determined after delivery for research purposes, and these
results were not used in patient management. A flowchart of our
overall approach to amniotic fluid analysis is illustrated in
Supporting Figure S1; detailed experimental methods, including
microbiologic techniques and IL-6 quantitation, appear in
Supporting Materials and Methods S1.
Molecular analysis
Microbial genomic DNA was extracted from 200 ml of each
amniotic fluid sample. Qualitative analysis was achieved by means
of three separate broad-range end-point PCR assays targeting
rDNA of either bacteria, fungi, or archaea. Cloned amplicons (up
to 24 clones per positive PCR reaction) were bidirectionally
sequenced, the sequences aligned, and then subjected to
phylogenetic analysis (621 nucleotide positions). Quantitative
rDNA analysis was achieved by means of three real-time PCR
assays corresponding to each of the three microbial groups
targeted by end-point PCR. Methodologic details of the key
aspects of our molecular approach (including nucleic acid
extraction, PCR assays, phylogenetic analysis, and contamination
prevention) appear under Supporting Materials and Methods S1;
PCR primer and probe sequences appear in Supporting Table S4.
Outcome Measures
In order to assess the clinical significance of the microbes
detected with molecular methods, pre-specified outcome variables
from four broad categories were measured: 1) markers of intra-
amniotic inflammation (including amniotic fluid WBC count [19]
and IL-6 concentration [20]); 2) histopathologic evidence of
maternal or fetal inflammation (including chorioamnionitis and
funisitis); 3) pregnancy outcomes (including gestational age at
delivery, and amniocentesis-to-delivery interval); and 4) neonatal
outcome. Neonatal outcome was assessed by measuring composite
neonatal morbidity and mortality, defined as the presence of one
or more of the following: bronchopulmonary dysplasia, respiratory
distress syndrome, necrotizing enterocolitis, intraventricular he-
morrhage$grade III, and sepsis, which were diagnosed according
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requiring mechanical ventilation, and neonatal death.
Statistical analysis
Statistical analyses were performed using ‘R’ (open source,
www.r-project.org) version 2.4.1, including the ‘Epi’ and ‘Survival’
packages. For gestational outcomes, patients with an episode of
spontaneous preterm labor who delivered at term served as
controls. Positive predictive values were estimated by means of
contingency table analysis. Differences in the median between
groups were computed using the Mann Whitney U test when two
groups were compared and the Kruskal-Wallis analysis of variance
test when more than two groups were compared. Unadjusted and
adjusted odds ratios (OR) for binary outcomes were estimated by
simple and multiple logistic regression modeling, respectively.
Correlation coefficients for continuous outcomes were estimated
by means of least squares linear regression modeling. Time-to-
event outcomes were modeled by Kaplan-Meier survival methods;
differences between survival curves were evaluated by the Mantel-
Haenszel log-rank test, and proportional hazard ratios were
estimated by the method of Cox. For all analyses, a two-tailed P
value ,0.05 was considered significant. Additional details of the
statistical methods used, including the calculation of false discovery
rates for P values corresponding to multiple pairwise comparisons,
appear under Supporting Materials and Methods S1.
Results
Of 166 subjects, 53 (32%) delivered at term and 113 (68%)
delivered preterm (Figure 1A). Ten patients (6%) had clinical
chorioamnionitis. Baseline characteristics appear in Supporting
Table S1.
Microbial prevalence and diversity
Microbial invasion of the amniotic cavity – as defined by either
a positive end-point PCR or culture of amniotic fluid – was found
in 15% (25/166) of patients. Of these, bacteria were cultivated
from 15 and a fungus from 1, whereas bacterial rDNA was
amplified from 17 and fungal rDNA from 2. Six culture-positive
samples were negative by PCR, and nine PCR-positive samples
were negative by culture (Figure 1B). No archaea were detected.
Figure 1. Gestational Outcomes and Amniotic Fluid Findings. Panel A shows outcomes of enrolled subjects. Panel B summarizes results of
culture and PCR analysis of amniotic fluid. PCR refers to end-point PCR for bacteria, fungi and archaea. Culture refers to the use of routine cultivation
methods for bacteria (aerobic, anaerobic and genital mycoplasmas) and fungi. Circle areas are not to scale.
doi:10.1371/journal.pone.0003056.g001
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for cytomegalovirus (CMV) was performed on 79 samples. Of
these, 2.5% (2/79) were positive; both subjects delivered full-term
neonates.
Among the 25 patients whose amniotic fluid tested positive by
culture or end-point PCR, 17 bacterial species (belonging to 5
phyla) and 1 fungal species were identified. Of the 17 bacterial
taxa identified, 6 were detected by both culture and PCR
(Mycoplasma hominis, Ureaplasma sp., Streptococcus agalactiae, Lactoba-
cillus sp., Prevotella sp., and Fusobacterium nucleatum), 4 were detected
by culture only (coagulase-negative Staphylococcus sp., Bacillus sp.
not anthracis, Peptostreptococcus sp., and Gardnerella vaginalis), and 7
were detected by PCR only (Streptococcus mitis, uncultivated
Bacteroidetes bacterium, Delftia acidovorans, Neisseria cinerea, Sneathia
(formerly Leptotrichia) sanguinegens, Leptotrichia amnionii, and one
phylotype (clone PL036-b24) with ,95% rDNA sequence identity
to its closest Genbank relative that appeared to represent a novel
species) (Figure 2). The single fungal species identified was Candida
albicans. The fastidious nature of many taxa detected only by PCR
(e.g. S. sanguinegens and L. amnionii) supported the underlying
premises of this study. Characteristics of individual subjects testing
positive by PCR or culture, including GenBank accession numbers
of rDNA sequences, are detailed in Supporting Table S2. We next
investigated the relevance of molecular detection of these diverse
taxa in the population as a whole by examining associations with
host inflammation, and seeking evidence for categorical, temporal,
and dose-response associations with preterm delivery.
Association of intra-amniotic microbial DNA with host
(maternal and fetal) inflammation
A host inflammatory response has been implicated in the
pathogenesis of preterm delivery [8]. In order to evaluate the
association between microbial DNA and intra-amniotic inflam-
mation, results from end-point PCR and culture were correlated
with amniotic fluid WBC count and IL-6 concentration, which
typically are elevated in the setting of infection [19,21,22]. Figure 3
shows that the median amniotic fluid WBC count and IL-6
concentration in the PCR-positive / culture-negative (P+/C2)
group were higher than the median concentrations of each marker
in the P2/C2 group (P,0.001 for WBC and for IL-6), and
equivalent to the median concentrations of each respective marker
in the P2/C+ group (P=0.22 for WBC; P=0.27 for IL-6). These
results indicate that the inflammatory response in the amniotic
cavity of patients who are positive only by PCR is as robust as the
inflammatory response in those who are positive only by culture.
In addition, the median WBC count and IL-6 concentration in the
P+/C+ group were higher than the median concentrations of each
respective marker in the P2/C+ group (for WBC, P=0.02, false
discovery rate 152/1000; for IL-6, P=0.004, false discovery rate
45/1000) (Figure 3), suggesting that a positive PCR result may be
clinically significant even in the setting of a positive culture.
To evaluate associations of microbial DNA with inflammation
of maternal and fetal tissues, results from end-point PCR and
culture were correlated with histologic chorioamnionitis, which
has been previously associated with preterm delivery [23], and
Figure 2. Microbial Diversity. Phylogeny of the 17 bacterial taxa identified in this study, based on a maximum likelihood algorithm. Colored boxes
indicate the number of subjects who were positive for a given taxon by culture (gray) or PCR (blue) (some samples were polymicrobial). For most
individual taxa, the larger of the two numbers in the corresponding gray or blue box represents the total number of positive subjects; for taxa where
neither method detected all positive subjects, the total number is shown in the white box. A 99% sequence similarity cutoff threshold was used for
phylotype assignment, which was based on 621 unambiguous nucleotide positions. Bergeyella sp. (bracketed and in gray type) is included as a
reference species only and was not detected in the study population. A single fungal species, Candida albicans, was detected by culture in 1 subject
and by PCR in 2 (data not shown). GenBank accession numbers of bacterial and fungal rDNA sequences from this study appear in Supporting Table
S2.
doi:10.1371/journal.pone.0003056.g002
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logistic regression modeling. After controlling for other covariates
exhibiting statistically significant associations (see Table 1), the
adjusted ORs of PCR and of culture for histological chorioam-
nionitis were 20 (95% CI, 2.4 to 172) and 8.6 (95% CI, 1.0 to 76),
respectively; the adjusted ORs of PCR and of culture for funisitis
were 18 (95% CI, 3.1 to 99) and 5.8 (95% CI, 1.1 to 32),
respectively.
Association of intra-amniotic microbial DNA with
gestational and neonatal outcomes
To evaluate the association of microbial DNA with gestational
outcomes, results from end-point PCR and culture were correlated
with gestational age at delivery. All subjects testing positive by
either PCR or culture delivered preterm; this complete separation
with respect to test result precluded logistic regression analysis.
However, when the study population was stratified according to
clinically-relevant gestational-age cut offs, the frequency distribu-
tion of positive PCR assays exhibited a clear inverse relationship
with gestational age at delivery (Figure 4A). The positive predictive
value of PCR for delivery before 37-, 32-, and 25-weeks was 100%
for each time point (Table 2).
To evaluate the association of microbial DNA with neonatal
outcomes, results from end-point PCR and culture were correlated
with a composite of neonatal morbidity and mortality by means of
simple and multiple logistic regression. Similar to the outcome of
preterm delivery, both PCR and culture exhibited near-complete
positive correlation: all but two PCR-positive cases, and all but one
culture-positive case were associated with neonatal morbidity and
mortality (Supporting Table S2). Although this led to wide
confidence limits in the logistic regression models, the magnitude
of the odds ratios suggests a significant association for both PCR
and culture [adjusted OR 5.2 (95% CI, 0.84 to 32) and 7.1 (95%
CI, 0.66 to 76), respectively] (Table 1).
Temporal and dose response associations
To evaluate the association of microbial DNA with timing of
delivery, results from end-point PCR and culture were correlated
with the interval from amniocentesis to delivery. Kaplan-Meier
survival estimates, censored for subjects in whom labor was
augmented, and evaluated for differences by means of the Mantel-
Haenszel log-rank test, revealed an overall association between a
positive test result (PCR and/or culture) and a shortened
amniocentesis-to-delivery interval (P,0.001) (Figure 4B). Pairwise
comparison of the two cohorts who were positive by one method
alone (i.e., P+/C2 vs. P2/C+) revealed no difference in the
amniocentesis-to-delivery interval of subjects who were positive
only by PCR as compared with those who were positive only by
culture (P=0.5), indicating that a positive PCR alone is as
significant as a positive culture alone (Figure 4B). However,
pairwise comparison of the two cohorts testing positive by culture
(i.e., P+/C+ vs. P2/C+) demonstrated a shorter amniocentesis-to-
delivery interval for subjects who were positive by both culture and
PCR as compared with those who were positive by culture but
negative by PCR (P=0.025, false discovery rate 26/1000)
(Figure 4B). These unexpected findings support independent
prognostic value for PCR even in the setting of a positive culture.
The positive predictive value of PCR or culture for delivery within
one day of amniocentesis was approximately 68% for either
method alone, and 100% for both methods combined (Table 2).
Cox proportional hazards regression, adjusted for nine covariates,
estimated the hazard ratio of a positive PCR to be 4.6 (95% CI,
2.2 to 9.5), and of a positive culture to be 6.4 (95% CI, 2.8 to 15)
(Supporting Table S3).
To evaluate dose-response associations, bacterial rDNA con-
centration was estimated by broad-range real-time PCR, and
correlated with gestational age at delivery. Regression modeling
revealed a significant correlation (r
2=0.42; P,0.002) (Figure 5).
Discussion
This study revealed significant associations between the
presence and quantity of microbes or their DNA in amniotic
Figure 3. Correlation of PCR and Culture Results with Markers
of Infection in Amniotic Fluid. Amniotic fluid concentrations of
white blood cells (WBCs) (Panel A) and interleukin-6 (IL-6) (Panel B) as a
function of PCR and culture results. Each circle represents one subject;
each horizontal bar and adjacent number indicates the median value
for that group. P values were calculated by means of the Mann-Whitney
U test. PCR refers to end-point PCR for bacteria, fungi and archaea.
Culture refers to the use of routine cultivation methods for bacteria
(aerobic, anaerobic and genital mycoplasmas) and fungi.
doi:10.1371/journal.pone.0003056.g003
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Microbial prevalence, as revealed by means of end-point PCR and
culture combined (15%), was 56% higher than that found by
culture alone (9.6%), which is the conventional diagnostic
approach. PCR detected microbial DNA in culture-negative
samples despite the limited sample volumes available for DNA
extraction (200 ml per patient), and the fact that PCR was
performed 2 to 6 years after sample collection and culturing,
which may have limited the number of PCR-positive samples
owing to DNA degradation [24]. The prevalence of a positive
amniotic fluid culture/PCR was inversely related to gestational
age at delivery, reflecting a previously-reported pattern [9].
Importantly, compared to both methods combined, culture
exhibited a false negative rate of 27% (3/11) in subjects delivering
before 25 weeks (Figure 4A), a cohort with a neonatal mortality
rate exceeding 70% in meta-analyses [25]. This underscores the
need for improved diagnostic assays in this setting.
The microbial diversity revealed by end-point PCR and culture
combined (18 taxa) was almost twice as rich as that found by
culture alone (11 taxa). Among the taxa identified by PCR, but not
culture, were phylotypes that would not have been predicted from
prior studies. One taxon appeared to be a novel species, and
possibly a novel genus. The sequence of this taxon (clone PL036-
b24; GenBank accession no. EU932745) clustered nearest the
genus Leptotrichia within the phylum Fusobacteria (Figure 2). Two
other fastidious members of this phylum went undetected by
culture: Leptotrichia amnionii (n=2) and Sneathia (formerly Leptotrichia)
sanguinegens (n=4). The latter was the third most frequently
encountered taxon overall (Figure 2). Both taxa were provided
valid species descriptions only recently [26,27]. Sporadic reports of
their detection in peripartum bacteremia [28–30], pyosalpinx
[31,32], and in amniotic fluid [27,33,34] associated with various
clinical syndromes, suggest they possess pathogenic potential. L.
amnionii has also been associated with bacterial vaginosis [14], a
condition conferring an approximately two-fold risk of preterm
delivery [35–37]. This study extends support for Leptotrichia sp.,
Sneathia sp. and related taxa as intra-amniotic pathogens, and
suggests that their prevalence in the setting of preterm labor is
underestimated. For other bacterial phylotypes detected only by
PCR (Delftia acidovorans [Genbank accession no. EU932748],
uncultured Bacteroidetes bacterium [Genbank accession
no. EU932749], and Neisseria cinerea [Genbank accession
no. EU932746]), we found no reports of their previous detection
in either human amniotic fluid or maternal-fetal membranes.
A single fungal phylotype, Candida albicans, was detected in two
subjects, both of whom were PCR-positive, and one of whom was
culture-positive. We detected no members of Archaea,t h em o s t
recently characterized domain of life [38]. This suggests that if
archaea are capable of amniotic cavity invasion, this occurs rarely or
involves abundance levels below the detection thresholdof our assays.
Prior studies have applied species-specific [10,11,39–44] or
broad-range [33,34,45–47] PCR to amniotic fluid, within various
clinical settings. These early investigations yielded insights but had
limitations. Indeed, the broad-range studies involved small sample
sizes, and included rDNA sequencing that was limited [33],
shallow (one sequence per positive PCR reaction) [34,46], or
absent [45,47]. These studies also lacked measures of microbial
abundance. Cumulatively, however, these important studies
demonstrated the sensitivity of PCR in this setting, including the
potential for detecting fastidious taxa such as Ureaplasma spp., and
revealed associations with certain outcomes.
To overcome limitations of prior studies, we analyzed 166
subjects for microbes belonging to three broad taxonomic groups.
Microbial diversity was assessed by sequencing up to 24 clones per
subject. Microbial rDNA abundance was measured in parallel.
Using this approach, we demonstrated greater microbial diversity
than expected from prior studies. Compared to findings from
culture, the molecular detection of these diverse microbes
exhibited equivalent associations with indices of host inflamma-
tion, and with adverse gestational and neonatal outcomes.
Our study does not prove causation. To do so for multifactorial
biological phenomena often entails successive investigations that
expand knowledge within a coherent framework until sufficient
evidence accumulates. Any single framework, however, may have
limitations. The postulates of Robert Koch, for example, cannot
be fulfilled for uncultivated pathogens [48]. However, an
alternative causal framework based on epidemiologic guidelines
proposed by Sir Austin Bradford Hill [49] may be particularly
appropriate for molecular investigations [16]. Of Hill’s nine
criteria, our broad-range molecular findings demonstrate statistical
Table 1. Factors Associated with Histologic Chorioamnionitis, Funisitis, and Neonatal Morbidity and Mortality.
Variable
Histologic Chorioamnionitis*
(n=57) Funisitis{ (n=48)
Composite Neonatal Morbidity and
Mortality{ (n=63)
Univariate Multivariate Univariate Multivariate Univariate Multivariate
Positive amniotic fluid PCR 37 (4.8–288) 20 (2.4–172) 24 (5.2–109) 18 (3.1–99) 16.2 (3.6–73) 5.2 (0.84–32)
Positive amniotic fluid culture 31 (4.0–243) 8.6 (1.0–76) 20 (4.2–91) 5.8 (1.1–32) 23 (2.9–179) 7.1 (0.66–76)
Maternal age 0.99 (0.93–1.0) 0.97 (0.90–1.0) 0.95 (0.89–1.0) 0.9 (0.84–0.98) 1.0 (0.97–1.1) NA
Gestational age at amniocentesis 0.87 (0.80–0.94) 0.89 (0.81–0.97) 0.9 (0.81–0.96) 0.89 (0.83–0.98) 0.84 (0.78–92) 0.80 (0.72–0.88)
Cervical dilatation 1.1 (0.91–1.4) NA 1.1 (0.90–1.4) NA 1.4 (1.1–1.7) 1.6 (1.2–2.1)
Results are reported as odds ratios (95% confidence interval).
The table includes variables that exhibited a statistically significant association with one or more of the three measured outcomes. For each outcome, the multivariate
model was comprised of those variables exhibiting a significant association in the univariate model. Other variables that were subject to univariate analysis but did not
exhibit a significant association with any of these outcomes were: African-American race, nulliparity, previous preterm delivery, cigarette smoking, and recreational drug
use.
*Diagnosed based on the presence of inflammatory cells in the chorionic plate and/or chorioamniotic membranes.
{Defined as the presence of neutrophils in the wall of the umbilical vessels and/or Wharton’s jelly.
{Defined as the presence of any one or more of the following: bronchopulmonary dysplasia, respiratory distress syndrome, necrotizing enterocolitis, intraventricular
hemorrhage of grade$III, sepsis, respiratory failure requiring mechanical ventilation, and neonatal death.
NA Not applicable.
doi:10.1371/journal.pone.0003056.t001
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biological gradient. Additionally, our study augments a fourth
general criterion of consistency of association (similar findings over
multiple investigations using different methodology), and conforms
to criteria of coherence, plausibility, analogy and experimentation
as they pertain to intra-amniotic infection [8,50].
Despite this study’s progress in defining the microbial diversity
associated with preterm delivery, much likely awaits discovery.
Figure 4. Gestational Outcomes According to Results of Culture and PCR. Panel A shows the proportion of subjects from each gestational
age cohort who were positive by culture or PCR. The total of number of subjects in each cohort appears across the top of the graph, and the number
of positive subjects appears above each bar. Panel B is a Kaplan-Meier analysis of amniocentesis-to-delivery interval according to culture and PCR
results. Subjects in whom labor was augmented were censored and are represented by crosses. P values were calculated by means of the Mantel-
Haenszel log-rank test. The inset table shows the median interval for each group. For both panels, PCR results refer to end-point PCR for bacteria,
fungi and archaea, and culture refers to the use of routine cultivation methods for bacteria (aerobic, anaerobic and genital mycoplasmas) and fungi.
doi:10.1371/journal.pone.0003056.g004
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bacterium (GenBank accession no. EU932749) and the previously-
uncharacterized Fusobacteria bacterium (GenBank accession
no. EU932745), were singletons that have been rarely, if ever,
reported from human amniotic fluid. It can thus be inferred, based
on ecological approaches for estimating species richness in
sampled environments [51], that the amniotic cavity remains a
largely unexplored niche.
This study has some limitations, some of which could affect
results from molecular assays disproportionately, thus potentially
contributing to a negative PCR in some culture-positive cases.
First, DNA may have degraded during the interval from
amniocentesis to molecular analysis (range, 2–6 years) [24],
rendering it non-amplifiable in some samples. Second, the starting
sample volume of 200 ml was probably suboptimal for use with
broad-range PCR assays, which are less sensitive than species-
specific PCR assays. Third, molecular findings may have been
affected by PCR inhibition [52], or by biases in DNA extraction
[52], PCR amplification efficiency [52], or PCR primer specificity
[53]. Fourth, our approach may have failed to detect phylotypes
present in polymicrobial samples at low relative abundance. Last,
we did not target viruses or non-fungal eukaryotic microbes.
In conclusion, among patients with spontaneous preterm labor
and intact membranes, the amniotic cavity harbors a greater
diversity of microbes than previously suspected, including
uncultivated, previously-uncharacterized taxa. The strength,
temporality and gradient with which detected microbes were
associated with clinically relevant outcomes, including preterm
delivery, suggest a causal relationship. Despite these insights, the
microbial census of the amniotic cavity is unfinished. Taken
together, our findings support a contributory role for occult intra-
amniotic infection in preterm delivery and its neonatal sequelae,
and argue for further large-scale prospective molecular investiga-
tions.
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